ORIC Pharmaceuticals, Inc.
ORIC
$4.99
-$0.27-5.13%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.04% | -8.14% | -27.80% | 11.72% | -11.19% |
| Total Depreciation and Amortization | 12.59% | -0.74% | 4.21% | -0.76% | 2.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.76% | 15.19% | -1.14% | 50.63% | -6.64% |
| Change in Net Operating Assets | 83.34% | -29.03% | 141.21% | -511.64% | -45.40% |
| Cash from Operations | 2.58% | -12.38% | 15.11% | -24.38% | -23.54% |
| Capital Expenditure | 47.61% | -25.53% | -52.75% | -282.46% | 25.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 82.54% | 26.19% | 130.19% | -393.29% | 136.40% |
| Cash from Investing | 84.89% | 26.20% | 129.55% | -395.13% | 136.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 356.35% | -84.56% | -99.35% | 27,476.65% | 1,364.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -16,700.00% | -- |
| Cash from Financing | 356.35% | -84.56% | -99.35% | 27,500.44% | 1,361.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 370.95% | 14.21% | -119.80% | 1,255.43% | 96.31% |
